Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: Elevated circulating level of β-aminoisobutyric acid (BAIBA) in heart failure patients with type 2 diabetes receiving sodium-glucose cotransporter 2 inhibitors

Fig. 2

Distribution of standardized mean difference before and after inverse probability of treatment weighting. IPTW, inverse probability of treatment weighting; LVEF, left ventricular ejection fraction; BMI, body mass index; NT-proBNP, N-terminal pro-brain natriuretic peptide; eGFRcys, cystatine C-based estimated glomerular filtration rate; RASi, renin-angiotensin system inhibitors; HbA1c, glycated hemoglobin A1c; New York Heart Association; DPP4i, dipeptidyl peptidase 4 inhibitors; MRA, mineralocorticoid receptor antagonists.

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840